ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
RAPT Therapeutics Inc

RAPT Therapeutics Inc (RAPT)

1.81
0.08
(4.62%)
At close: December 26 3:00PM
1.7991
-0.0109
( -0.60% )
After Hours: 4:03PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.150.400.370.2750.1248.00 %4201,31914:49:50
5.000.050.200.100.1250.05100.00 %3124913:03:02
7.500.050.150.090.100.0480.00 %526013:17:01
10.000.050.100.050.0750.000.00 %243210:47:22
12.500.050.050.050.050.000.00 %07-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
2.500.801.750.901.2750.055.88 %479112:23:13
5.003.103.403.103.25-0.10-3.13 %1511:42:52
7.505.505.905.805.700.000.00 %01-
10.008.008.300.008.150.000.00 %00-
12.5010.5010.800.0010.650.000.00 %00-

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EVAXEvaxion Biotech AS
US$ 1.69
(99.76%)
6.4M
KITTNauticus Robotics Inc
US$ 2.74
(53.93%)
2.26M
LIDRAEye Inc
US$ 1.7896
(39.81%)
936.14k
CRKNCrown Electrokinetics Corporation
US$ 0.174
(32.12%)
20.07M
OMEXOdyssey Marine Exploration Inc
US$ 0.599
(24.66%)
8.92M
VIRXViracta Therapeutics Inc
US$ 0.2005
(-15.40%)
286.82k
LKCOLuokung Technology Corporation
US$ 1.60
(-13.98%)
14.12k
CTCXCarmell Corporation
US$ 0.277
(-13.98%)
128.52k
RAYRaytech Holding Ltd
US$ 1.39
(-12.03%)
10.88k
SLGLSol Gel Technologies Ltd
US$ 1.08
(-11.48%)
24.2k
CRKNCrown Electrokinetics Corporation
US$ 0.1751
(32.95%)
20.14M
OMEXOdyssey Marine Exploration Inc
US$ 0.60
(24.87%)
8.93M
EVAXEvaxion Biotech AS
US$ 1.69
(99.76%)
6.41M
RGTIRigetti Computing Inc
US$ 15.34
(-0.65%)
3.27M
XTIAXTI Aerospace Inc
US$ 0.0403
(0.75%)
3.21M

RAPT Discussion

View Posts
tbonaces80 tbonaces80 4 hours ago
Gonna breakout above $2.11. Hold for major move. Shares gobbled on this wedge
πŸ‘οΈ0
glenn1919 glenn1919 4 hours ago
RAPT......................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
tw0122 tw0122 8 hours ago
$2.20 + 20%
πŸ‘οΈ0
tbonaces80 tbonaces80 11 hours ago
Wainwright ups price to $10. This will be going parabolic 
πŸ‘οΈ0
tbonaces80 tbonaces80 21 hours ago
We go hard this week. Too many Capital firms bought in. Load the boat $6-$10 easy
πŸ‘οΈ0
tbonaces80 tbonaces80 1 day ago
This will hit $6 easily. Analysts know. Huge funding.  Foully loaded. 
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 1 day ago
@tbonaces80 @Princess17
What do you two think about this?
150 million pp says massively misunderstood story? 140mn historical volume too...
πŸ‘οΈ0
tbonaces80 tbonaces80 2 days ago


πŸ‘οΈ0
tbonaces80 tbonaces80 2 days ago
Load zone. 
πŸ‘οΈ0
Princess17 Princess17 3 days ago
👍🏻 looks good 
πŸ‘οΈ0
tbonaces80 tbonaces80 3 days ago
Upgrade. Wells. Yup 
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 3 days ago
see chart and compare PP to market cap
must be massively misunderstood

also had a license agreement today
Regards
πŸ‘οΈ0
bigbux1 bigbux1 3 days ago
What am I missing? They just did a private placement of 100,000,000 shares of common stock at a purchase price of $0.85 per share and this soars past 1.50?
πŸ‘οΈ0
Mister Mr Mister Mr 3 days ago
Keep pumping! Let's go!!!
πŸ‘οΈ0
glenn1919 glenn1919 3 days ago
rapt........................https://stockcharts.com/h-sc/ui?s=rapt&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
PonkenPlonken PonkenPlonken 3 days ago
https://www.globenewswire.com/news-release/2024/12/23/3001133/0/en/RAPT-Therapeutics-Announces-150-Million-Private-Placement.html
wow!
market cap 30 million no discount
πŸ‘οΈ0
Invest-in-America Invest-in-America 3 days ago
RAPT:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175569055
πŸ‘οΈ0
tw0122 tw0122 3 days ago
RAPT up 15% news and TRAW also up $13.77 + 150% TRAW up big
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
RAPT.........................https://stockcharts.com/h-sc/ui?s=RAPT&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RAPT under $3
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RAPT new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
RAPT new 52 low
πŸ‘οΈ0
Monksdream Monksdream 5 months ago
RAPT under $4
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
RAPT new 52 week
πŸ‘οΈ0
Monksdream Monksdream 8 months ago
RAPT under $10
πŸ‘οΈ0
tickersym tickersym 10 months ago
Bargin prices!! Lets go!!
πŸ‘οΈ0
Stockexpertpro Stockexpertpro 10 months ago
RAPT Only 1 Patient had a problem out of 350 people enrolled in the trial

https://finance.yahoo.com/news/1-fda-puts-hold-two-125809258.html Fire sale down here lots of upgrades out last weeK
πŸ‘οΈ0
StockLogistics StockLogistics 2 years ago
Surprised that no gap fill occurred prior to results expected near September 12, showing major strength buoyed by estimates of 50.00:

β€œ8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, today announced it has initiated its 16-week randomized, double-blind, placebo-controlled Phase 2b clinical trial to further evaluate the efficacy and safety of RPT193 as monotherapy in patients with moderate-to-severe atopic dermatitis (AD).”
πŸ‘οΈ0
StockLogistics StockLogistics 3 years ago
12.16 gap fill over the next 14.5 weeks
πŸ‘οΈ0
StockLogistics StockLogistics 3 years ago
12.16 gap fill over the next 14.5 weeks
πŸ‘οΈ0
StockLogistics StockLogistics 3 years ago
15 weeks to go

8:04a ET 5/23/2022 - Benzinga
RAPT Therapeutics Announces Initiation Of Phase 2b Trial Of RPT193 In Patients With Moderate-to-Severe Atopic Dermatitis

Countdown to potential billions in revenue.
πŸ‘οΈ0
StockLogistics StockLogistics 3 years ago
A ton of insider buying last week
πŸ‘οΈ0
StockLogistics StockLogistics 3 years ago
Positive sentiment about billions that could be made from Rapt’s drug and pipe financing, perfect storm brewing
πŸ‘οΈ0
Glider549 Glider549 4 years ago
It happens,,and more often than not doesn't.
That's why I'd trim, but leave some on the table.
πŸ‘οΈ0
weasel4339 weasel4339 4 years ago
It's way up after hours bud
πŸ‘οΈ0
Glider549 Glider549 4 years ago
Can't believe some of you did not take profits near the close.
Greed will kill ya.
πŸ‘οΈ0
pennyfinder pennyfinder 4 years ago
Will do
πŸ‘οΈ0
weasel4339 weasel4339 4 years ago
I'll keep n eye out. Let me knoe if u hear something about the price
πŸ‘οΈ0
pennyfinder pennyfinder 4 years ago
Supposed to be. There’s no price set on the offering. They just said they’re raising $125M, they could be raising at $50… who knows… but the history has always been lower than the closing price. We will have to wait and see.
πŸ‘οΈ0
weasel4339 weasel4339 4 years ago
This considered dilution?
πŸ‘οΈ0
pennyfinder pennyfinder 4 years ago
LOL

https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-announces-proposed-public-offering-common
πŸ‘οΈ0
make it happen make it happen 4 years ago
Most def. Idk how these companies even give a PT like that. Happens way to often and retails get blindsided. I wouldn't even do that if had all the power too.
πŸ‘οΈ0
pennyfinder pennyfinder 4 years ago
Offering AH or tomorrow pre
πŸ‘οΈ0
make it happen make it happen 4 years ago
Negative 1,000% plus operating margins. Only Phase 1 still, A long way to go...

Large negative lose percentages across the board on margins.

Only $0.22 revenue per share

Cash flow will burn all money before end of year.

Profitability
Profit Margin 0.00%
Operating Margin (ttm) -1,064.70%

Management Effectiveness
Return on Assets (ttm) -27.62%
Return on Equity (ttm) -50.34%

Income Statement
Revenue (ttm) 5.33M
Revenue Per Share (ttm) 0.22
Quarterly Revenue Growth (yoy) 30.70%
Gross Profit (ttm) 5.04M
EBITDA -55.53M
Net Income Avi to Common (ttm) -56.27M
Diluted EPS (ttm) -2.29

Balance Sheet
Total Cash (mrq) 98.41M
Total Cash Per Share (mrq) 3.93
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 9.21
Book Value Per Share (mrq) 3.69

Cash Flow Statement
Operating Cash Flow (ttm) -45.66M
Levered Free Cash Flow (ttm) -23.3M
πŸ‘οΈ0
StockLogistics StockLogistics 4 years ago
This stock reported legitimate results of its study and is a short squeeze candidate imo if Reddit wanted to wake up to it
πŸ‘οΈ0
Roadtojourney Roadtojourney 5 years ago
Not even 6 months old and already offering??
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
RAPT Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It is developing selective small molecules designed to modulate the critical immune responses underlying these diseases. It has discovered and advanced two drug candidates FLX475 and RPT193, which is engaged in targeting C-C motif chemokine receptor 4 (CCR4). Its drug discovery and development engine has identified CCR4 as a drug target that potentially has broad applicability in oncology and inflammatory diseases. Its lead oncology drug candidate FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory Treg cells into tumors. Its RPT193 drug candidate, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells), into allergically-inflamed tissues.
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
42.00 > hod.

RAPT
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
29.01 x 30.00

RAPT
πŸ‘οΈ0
crudeoil24 crudeoil24 5 years ago
Multiple Nasdaq circuit breakers halts today

RAPT
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock